BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25178848)

  • 1. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel.
    Vaidya GN; Acevedo R
    Am J Emerg Med; 2015 Feb; 33(2):308.e1-2. PubMed ID: 25178848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.
    Wright JL; Lin DW; Dewan P; Montgomery RB
    Int J Urol; 2005 Nov; 12(11):1012-3. PubMed ID: 16351664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
    Drakos P; Bar-Ziv J; Catane R
    Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-induced acral erythema.
    Richards KN; Ivan D; Rashid RM; Chon SY
    Arch Dermatol; 2012 Nov; 148(11):1333-4. PubMed ID: 23165853
    [No Abstract]   [Full Text] [Related]  

  • 5. Paclitaxel-induced cardiotoxicity. An ultrastructural study.
    Shek TW; Luk IS; Ma L; Cheung KL
    Arch Pathol Lab Med; 1996 Jan; 120(1):89-91. PubMed ID: 8554453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.
    Yahata T; Nishikawa N; Aoki Y; Tanaka K
    Gynecol Oncol; 2006 Nov; 103(2):752-4. PubMed ID: 16857250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer.
    Sorscher SM
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):191-2. PubMed ID: 15148627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-leaking Cystoid Maculopathy Secondary to Systemic Paclitaxel.
    Modi D; Dubovy SR
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):183-6. PubMed ID: 23429715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 12. Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma.
    Altundag K; Dede DS; Purnak T
    J Clin Pathol; 2007 Aug; 60(8):958. PubMed ID: 17660346
    [No Abstract]   [Full Text] [Related]  

  • 13. Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings.
    Wong P; Leung AN; Berry GJ; Atkins KA; Montoya JG; Ruoss SJ; Stockdale FE
    AJR Am J Roentgenol; 2001 Mar; 176(3):718-20. PubMed ID: 11222212
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudomembranous colitis in a patient treated with paclitaxel for carcinoma of the breast: a case report.
    Ang P; Cheong WK; Khoo KS
    Ann Acad Med Singap; 2000 Jan; 29(1):132-4. PubMed ID: 10748982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].
    Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
    Morkas M; Fleming D; Hahl M
    J Clin Oncol; 2002 Feb; 20(3):867-9. PubMed ID: 11821473
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in taxane therapy for metastatic breast cancer.
    ONS News; 2004; 19(9 Suppl):75-6. PubMed ID: 15478598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients].
    Kawamura M; Nakano S; Kyoda S; Tabei I; Yoshida K; Takeyama H
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):909-12. PubMed ID: 23863734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic metastasis in breast cancer: a case report.
    Park SB; Kim HH; Shin HJ; Paik MH; Kim DB; Gong G
    Korean J Radiol; 2007; 8(4):360-3. PubMed ID: 17673850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.